Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
AbbVie Inc. (ABBV) had Normalized Pre-Tax Income of $6.60B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$61.16B |
|
$4.23B |
|
$18.20B |
|
$42.96B |
|
$46.09B |
|
$15.07B |
|
$-8.36B |
|
$6.60B |
|
|
Normalized Pre-Tax Income |
$6.60B |
$4.23B |
|
$4.23B |
|
$4.23B |
|
$4.23B |
|
$15.07B |
|
$15.07B |
|
-- |
|
1.77B |
|
-- |
|
$2.36 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|